ILADAC DSR CAPSULE contains Domperidone and Ilaprazole which belongs to the group of medicines called Antiemetics and Proton pump inhibitors respectively. It is used in the treatment of gastro-esophageal reflux disease (GERD), peptic ulcer (a sore on the lining of your stomach, small intestine or esophagus), nausea and vomiting.
Gastroesophageal reflux disease (GERD) occurs when stomach acid frequently flows back into the tube connecting mouth and stomach (esophagus). This acid reflux can irritate the lining of esophagus. The symptoms include heartburn, chest pain, difficulty swallowing, sensation of a lump in your throat.
Before taking ILADAC DSR CAPSULE inform your doctor if you have heart, pituitary gland, kidney, liver problems, HIV/AIDS, bloody stools, blockage of intestine, problems with potassium/magnesium levels in blood. Avoid consumption of alcohol while taking ILADAC DSR CAPSULE.
Inform your doctor if you are pregnant or planning to have a baby. ILADAC DSR CAPSULE is not recommended for use in breastfeeding women. It is not recommended for use in children and adolescents below 12 years of age. The most common side effects of taking ILADAC DSR CAPSULE is dry mouth. Consult your doctor if symptom does not show improvement.
It is used to treat:
ILADAC DSR CAPSULE works by reducing excess stomach acid production and preventing the reflux of stomach acid into the food pipe in which Domperidone antagonizes the inhibitory effect of dopamine, resulting in stimulation of gastric muscle contraction which increases the gastric motility. And Ilaprazole works by suppressing gastric acid secretion through inhibition of the enzyme (H+/K+-ATPase) at the secretory surfaces of gastric parietal cells (responsible for gastric acid secretion).
Take ILADAC DSR CAPSULE as advised by your physician. Swallow the medicine with water. Do not crush or chew the medicine. Your doctor will decide the right dose and duration depending upon your age, body weight and disease condition.
Stop taking ILADAC DSR CAPSULE and contact your doctor immediately if you experience any of the following side effects:
Safety and effectiveness of ILADAC DSR CAPSULE in pregnant women has not been established yet so consult your doctor before taking it.
ILADAC DSR CAPSULE is not recommended for use in breastfeeding women as small amount may excreted in the breast milk and can affect the heart of the baby. Consult your doctor before taking it.
ILADAC DSR CAPSULE does not affect your ability to drive or use machines. Consult your doctor for advice.
Avoid consumption of alcohol while taking ILADAC DSR CAPSULE. Consult your doctor for advice.
ILADAC DSR CAPSULE should be used with caution in patients with liver disease. Dose will be adjusted by your doctor and kidney function will be monitored regularly. Consult your doctor before taking.
ILADAC DSR CAPSULE is not recommended for use in patients with moderate to severe liver disease. ILADAC DSR CAPSULE should be used with caution in patients with liver disease. Consult your doctor before taking.
Do not take ILADAC DSR CAPSULE if you are allergic to Domperidone or Ilaprazole or any other ingredients of this medicine.
ILADAC DSR CAPSULE is not recommended for use in patients with prolonged QT corrected interval and heart failure. Consult your doctor before taking.
ILADAC DSR CAPSULE is not recommended for use in children and adolescents below 12 years of age. Consult your doctor before taking the medicine.
ILADAC DSR CAPSULE is not recommended for use if you:
Before taking ILADAC DSR CAPSULE, inform your doctor if you:
A. Drug-Drug interactions:
Before taking ILADAC DSR CAPSULE, inform your doctor if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally took too much of ILADAC DSR CAPSULE, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are feeling sleepy, confused, uncontrolled movements (eye movements, unusual tongue movements or abnormal posture).
Drug | : | Domperidone, Ilaprazole |
Pharmacological Category | : | Dopamine antagonist, Proton pump inhibitor |
Therapeutic Indication | : | Gastro-esophageal reflux disease (GERD), Peptic ulcer, Nausea and Vomiting |
Dosage Forms | : | Tablet, Capsule |
Q: What is ILADAC DSR CAPSULE used for?
A: ILADAC DSR CAPSULE is used in the treatment of gastro-esophageal reflux disease (GERD), peptic ulcer (a sore on the lining of your stomach, small intestine or esophagus), nausea and vomiting.
Q: Can ILADAC DSR CAPSULE be used in breastfeeding women?
A: ILADAC DSR CAPSULE is not recommended for use in breastfeeding women as small amount is excreted in the breast milk and can affect the heart of the baby. Consult your doctor before taking it.
Q: Can ILADAC DSR CAPSULE be used in children?
A: ILADAC DSR CAPSULE is not recommended for use in children and adolescents below 12 years of age. Consult your doctor before taking this medicine.
Q: What if I accidentally take more of ILADAC DSR CAPSULE?
A: If you or anyone else accidentally take too much of ILADAC DSR CAPSULE, consult your doctor immediately or visit the nearby hospital. Symptoms of overdose are feeling sleepy, confused, uncontrolled movements (eye movements, unusual tongue movements or abnormal posture).
Q: How does ILADAC DSR CAPSULE work?
A: ILADAC DSR CAPSULE works by reducing excess stomach acid production and preventing the reflux of stomach acid into the food pipe in which Domperidone antagonizes the inhibitory effect of dopamine, resulting in stimulation of gastric muscle contraction which increases the gastric motility. And Ilaprazole works by suppressing gastric acid secretion through inhibition of the enzyme (H+/K+-ATPase) at the secretory surfaces of gastric parietal cells (responsible for gastric acid secretion).
1. KD Tripathi. Antiemetic, Prokinetic and Digestant Drugs. Essentials of medical pharmacology. Eighth Edition. 2019. Page – 715-716.
2. T Takahashi, S Kurosawa, J W Wiley, C Owyang. Mechanism for the gastrokinetic action of domperidone. In vitro studies in guinea pigs. [Accessed on 20th July 2022] https://pubmed.ncbi.nlm.nih.gov/1860634/#:~:text=The%20DA2%2Dreceptor%20antagonist%20domperidone,the%20gastrokinetic%20effect%20of%20domperidone.
3. Xi-Qing Ji, Jun-Feng Du, Gang Chen, Guang Chen, and Bo Yu. Efficacy of ilaprazole in the treatment of duodenal ulcers: A meta-analysis. [Accessed on 20th July 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009550/
4. Milpharm Limited. Electronic Medicines Compendium (EMC). [Revised in March 2021] [Accessed on 20th July 2022] https://www.medicines.org.uk/emc/files/pil.556.pdf
5. Janssen Pharmaceutica N.V. Health Products Regulatory Authority (HPRA). [Revised in February 2015] [Accessed on 20th July 2022] http://www.hpra.ie/img/uploaded/swedocuments/2155094.PA0823_051_004.28b5f597-4412-4a58-9c10-6e20449d4fd6.000001ProductLeaflet30mg.150312.pdf
6. Livzon. Ilaprazole. [Accessed on 20th July 2022] https://en.livzon.com.cn/product/8.html
7. Ilaprazole. Pubchem. [Revised in July 2022] [Accessed on 20th July 2022] https://pubchem.ncbi.nlm.nih.gov/compound/Ilaprazole
8. Ilaprazole. NIH. [Accessed on 20th July 2022] https://drugs.ncats.io/drug/776Q6XX45J
9. Domperidone+Ilaprazole. Mayoclinic. [Revised on May 2020] [Accessed on 20th July 2022] https://www.mayoclinic.org/diseases-conditions/gerd/symptoms-causes/syc 20361940#:~:text=Gastroesophageal%20reflux%20disease%20(GERD)%20occurs,reflux%20from%20time%20to%20time.
Written By Dr. Janet.C, Pharm.D
Last updated on 03 Mar 2023 | 06:26 PM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.